We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Changing the Future of Multiplexing content piece image
Industry Insight

Changing the Future of Multiplexing

In this interview, Greg Gosch shares insights into the science of multiplexing, discusses how ChromaCode is redefining molecular diagnostics and explores how HDPCR is shaping the future of what’s possible in COVID-19, related respiratory and other disease testing.
 Innovations in Single-Cell Proteomics Drive Advances in Disease Research content piece image
Industry Insight

Innovations in Single-Cell Proteomics Drive Advances in Disease Research

Single-cell technologies are transforming our knowledge of human health and disease. In this article, Gary Kruppa outlines the latest advances in single-cell proteomics.
Innovating Reversible Cell Therapies With RNA content piece image
Industry Insight

Innovating Reversible Cell Therapies With RNA

In this interview, Murat Kalayoglu, president and CEO of Cartesian Therapeutics discusses the company’s efforts to develop RNA-modified cell therapies that expand past oncology.
Using Artificial Intelligence To Detect Melanoma content piece image
Industry Insight

Using Artificial Intelligence To Detect Melanoma

To find out more about how AI can improve melanoma diagnosis, Technology Networks spoke to Dr. Kiran Motaparthi, director of dermatopathology and clinical associate professor of dermatology at the University of Florida and Julianna Ianni, PhD, vice president of AI R&D, Proscia.
Building the World’s First University Cloud Lab content piece image
Industry Insight

Building the World’s First University Cloud Lab

To learn more about the CMU Cloud Lab, the motivation behind the project and the benefits it will bring, Technology Networks spoke to Rebecca Doerge, PhD, dean, Mellon College of Science, Carnegie Mellon University, and Toby Blackburn, head of business development and research, Emerald Cloud Lab.
Early Detection of Brain Tumors and Beyond content piece image
Industry Insight

Early Detection of Brain Tumors and Beyond

The ability to detect a tumor earlier, when it is smaller, reduces the impact of surgery and treatment, improving the prognosis for many patients. Dxcover has developed a new spectroscopic liquid biopsy approach that is able to identify brain tumors as small as 0.2 cm3 from a blood sample in as little as fifteen minutes.
Gaining MOMENTUM in Optimizing the Clinical Use of Cutting-Edge, Personalized Cancer Treatments content piece image
Industry Insight

Gaining MOMENTUM in Optimizing the Clinical Use of Cutting-Edge, Personalized Cancer Treatments

This article explores how the expanded use of systematic, collaborative registries should allow the medical device, pharmaceutical and oncology communities to gain additional momentum on the road toward personalized cancer care.
Large-Scale Bioproduction of Adherent Cells To Support Advanced Therapy Workflows content piece image
Industry Insight

Large-Scale Bioproduction of Adherent Cells To Support Advanced Therapy Workflows

In recent years, a number of new cell and gene therapies have been developed to treat a variety of indications, including cancer and inherited retinal dystrophies. While these therapies have proven to be beneficial to patients, their scalability and manufacturability are two enduring challenges. Technology Networks spoke to Tara St.Amand, PhD, MBA, director of business technology, bioprocess at Corning to learn more about the key challenges faced when scaling up the manufacturing of cell products.
Genomic Testing Service To Drive Personalized Medicine for Cancer Patients content piece image
Industry Insight

Genomic Testing Service To Drive Personalized Medicine for Cancer Patients

The service will enable oncologists, hematologists and other healthcare professionals to undertake rapid and extensive genomic analysis of cancer samples on an unprecedented scale in the UK.
Unlocking the Power of Cancer Databases content piece image
Industry Insight

Unlocking the Power of Cancer Databases

An interview with LARVOL’s Sabrina Bellisario and Dr. Mark Gramling helps provide insights into the importance of precision medicine databases and how LARVOL is providing access to the information pharma and biotech companies need as they develop cancer treatments.
Advertisement